INBIONET, acronym standing for “INfection BIOlogy Training NETwork”, at the interface between microbiology, immunology and cellular biology, aims to explore some of the most novel themes that are beginning to emerge in the mechanisms by which pathogens manipulate host defence responses. Further, it is expected that this knowledge will lead to the development of innovative therapies based on the modulation of the host-pathogen interface.

The project is funded under the Marie Curie Initial Training Network scheme (ITN) as part of the EU’s Seventh Framework Programme (FP7) and will run from the 1st of January 2013 to 31st of December 2016. During the 4-year duration of the project a total of 15 fellows will receive training in all areas of infection biology research.

The Network integrates seven academic groups internationally recognized in the fields of microbial pathogenesis, innate immunity and molecular recognition, and intensive research SME, Preclin Biosystems, a multinational pharmaceutical company, Sanofi-Aventis, and is further supported by one associated partner (ParcBit, technological part).

Outreach & News

Another PhD viva success for INBIONET fellow

Read more

Bacteria: an essential enemy!

The latest report from Davide Massa looks at the important role that bacteria play in our everyday and concludes that the use of these small microorganisms has become an indispensable factor from research laboratories to biopharmaceutical companies.

Read more

The new threats of the world: emergent viruses

In his most recent report Francisco Dominguez explains why intensive research into emergent viruses continues to be of great importance worldwide.

Read more


Our latest Newsletter brings updates on first the INBIONET fellows to pass their PhD vivas, a new member of the team, recent publications and interesting reports from Sylviane Yoba, "mTOR: the multitask Protein" and  from Dr Olawale Salami,  "Seasonal Influenza vaccination".

Read more